当前位置:
X-MOL 学术
›
Cel. Mol. Bioeng.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Evaluation of the Antihemostatic and Antithrombotic Effects of Lowering Coagulation Factor VII Levels in a Non-human Primate.
Cellular and Molecular Bioengineering ( IF 2.8 ) Pub Date : 2020-03-23 , DOI: 10.1007/s12195-020-00613-4 Michael Wallisch 1, 2 , Sven R Olson 1, 3 , Jeffrey Crosby 4 , Jennifer Johnson 1 , Susan F Murray 4 , Joseph J Shatzel 1, 3 , Erik I Tucker 1, 2 , Owen J T McCarty 1, 3 , Monica T Hinds 1 , Brett P Monia 4 , András Gruber 1, 2, 3
中文翻译:
评估降低非人类灵长类动物凝血因子 VII 水平的抗止血和抗血栓作用。
更新日期:2020-03-23
Cellular and Molecular Bioengineering ( IF 2.8 ) Pub Date : 2020-03-23 , DOI: 10.1007/s12195-020-00613-4 Michael Wallisch 1, 2 , Sven R Olson 1, 3 , Jeffrey Crosby 4 , Jennifer Johnson 1 , Susan F Murray 4 , Joseph J Shatzel 1, 3 , Erik I Tucker 1, 2 , Owen J T McCarty 1, 3 , Monica T Hinds 1 , Brett P Monia 4 , András Gruber 1, 2, 3
Affiliation
Introduction
Tissue factor (TF) and factor (F) VII, components of the extrinsic pathway of blood coagulation, are essential for hemostatic plug formation in response to injury; less clear are their roles in propagating thrombosis, as observational data in humans with congenital FVII deficiency suggests persistent thrombotic and bleeding risk even at significantly decreased FVII levels. We aimed to define the contribution of FVII to thrombus formation and hemostasis using a non-human primate model.Methods
We treated baboons with a FVII antisense oligonucleotide (ASO) and measured platelet and fibrin deposition inside and distal to collagen- or TF-coated vascular grafts. We assessed hemostasis by measuring bleeding time (BT) and prothrombin time (PT). Enoxaparin and vehicle treatments served as controls.Results
FVII–ASO treatment reduced FVII levels by 95% and significantly increased both the PT and BT. Lowering FVII levels did not decrease platelet deposition in collagen- or TF-coated grafts, in thrombi distal to the grafts, or fibrin content of either collagen- and TF-coated grafts. Lowering FVII levels were associated with a modest 25% reduction in platelet deposition at 60 min in the distal thrombus tail of TF-coated grafts only.Conclusions
FVII inhibition by way of ASO is feasible yet significantly impairs hemostasis while only exhibiting antithrombotic effects when thrombosis is initiated by vessel wall surface-associated TF exposure.中文翻译:
评估降低非人类灵长类动物凝血因子 VII 水平的抗止血和抗血栓作用。